Skip to main content Skip to main navigation menu Skip to site footer
Drugs and Therapy Studies

eISSN 2038-9507

  • Archives
  • Register
  • Login
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Understanding the formulation variables of orodispersible tablets containing simvastatin solid dispersion using Box-Behnken design

    Ahmed Abd Elbary, Howida K. Ibrahim, Balquees S. Hazaa
    e7
    12-03-2012
    https://doi.org/10.4081/dts.2012.e7
    3045
    PDF: 942
  • Formulation and evaluation of colon targeted tablets containing simvastatin solid dispersion

    Ahmed Abd Elbary, Howida K. Ibrahim, Balquees S. Hazaa
    e16
    19-12-2011
    https://doi.org/10.4081/dts.2011.e16
    2598
    PDF: 1537
    Source of materials: 205
1 - 2 of 2 items

  • Self-reported adverse reactions associated with topical ophthalmic medication use: a cross-sectional survey
    23
  • Bevacizumab and etoposide combination chemotherapy in patients with recurrent malignant gliomas who failed bevacizumab
    12
  • Challenges and limitations of targeting cancer stem cells and/or the tumour microenvironment
    12
  • Impact of HIV subtype on response and resistance in antiretroviral-naïve adults comparing treatment with once daily versus twice daily ritonavir boosted fosamprenavir in combination with Abacavir/Lamivudine
    9
  • C11 cyclopentenone from the ascidian Diplosoma sp. prevents epidermal growth factor-induced transformation of JB6 cells
    9

Keywords

Analytics

Analytics

Drugs and Therapy Studies

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

pISSN: 2038-9493
eISSN: 2038-9507

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.